Dr Brijesh Srivastava

Consultant Hepatologist and Gastroenterologist

MB BS, MD (Camb), FRCP

"I enjoy working at Spire Cardiff where staff are very supportive and focused on improving patient care and outcomes. It has excellent facilities which help us deliver outstanding care for patients."

Specialises in

  • Flexible sigmoidoscopy
  • Gastroscopy

Also available for:

Virtual consultations:

I am a Consultant Hepatologist working at the University Hospital of Wales since 2015. I manage patients with all types of acute and chronic liver diseases and I am a competent endoscopist (including endoscopic management of varices).

I completed my specialist training in Hepatology at Addenbrookes Hospital, Cambridge. I was awarded Doctor of Medicine (MD) from Homerton College, University of Cambridge after the successful completion of my research in the largest UK wide population based study in PSC, to identify the clinical characteristics and the role of genetic risk factors in Primary Sclerosing Cholangitis (PSC).

I am the clinical lead for liver services at Cardiff and Vale University Health Board. I lead the RCP accredited ‘Improving Quality in Liver Services’ (IQILS) initiative here and I am also the Consultant Alcohol prevention champion. I am an active member of the Wales National Liver Disease Implementation Group, which works towards improving the standards of liver disease care in Wales.

My thorough training has enabled me to gain substantial clinical experience in different types of liver diseases such as metabolic and autoimmune liver disease; non-alcoholic fatty liver disease, viral hepatitis as well as alcohol related liver disease. I have performed over 2000 endosocopies (upper and lower GI) and I am competent in endoscopic management of oesophageal and gastric varices as per standards set by the British Society of Gastroenterology. I also perform ERCP in my NHS practice.

My sub-specialist research interest is in autoimmune and cholestatic liver diseases and I am the local principal investigator for the UK-PBC and UK-PSC studies. I have set up and lead the pathway for second line therapy for primary biliary cholangitis (PBC) in Wales. I believe in prudent healthcare and patient centered care and involve them in the decision making process about their health.


General Medical Council Number: C6062330

Treatment information

Some of the principal treatments carried out by Dr Brijesh Srivastava at Spire include:


Other treatments

  • Hepatology
  • Viral hepatitis
  • Upper GI endoscopy 

Get in touch

Important information about COVID-19 tests

COVID-19 testing or antibody tests are not available as a standalone service at Spire Cardiff Hospital.


Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Submit my enquiry

Additional information


MB BS / MAHE, India / 2003
Bachelor of Medicine, Bachelor of Surgery

MD / University of Cambridge / 2019
Doctor of Medicine

FRCP / London / 2019
Fellow of Royal College of Physicians

Professional memberships

General Medical Council

Medical Defence Union

Welsh Association for Gastroenterology and Endoscopy (WAGE)

British Association for the Study of the Liver (BASL)

British Society of Gastroenterology (BSG)

European Association for the Study of the Liver (EASL)

Professional leadership

I am the clinical lead for Hepatology services and also lead the national quality improvement project (IQILS) for Cardiff and Vale University Health Board. I also lead the Wales national pathway for second line treatment for Primary Biliary Cholangitis (PBC).

Consultant Hepatologist, University Hospital of Wales, Cardiff